Cargando…

Local Laboratory Testing of Germline BRCA Mutations vs. Myriad: A Single-Institution Experience in Korea

Genetic diagnosis for human epidermal growth factor receptor 2-negative metastatic breast cancer patients with the germline BRCA (gBRCA) mutation has been emphasized since the development of polyadenosine diphosphate-ribose polymerase inhibitors. Myriad Genetics, Inc.’s (Salt Lake City, UT, USA) com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Joohyun, Lee, Jiyun, Kwon, Minsuk, Kim, Ji-Yeon, Kim, Jong-Won, Ahn, Jin Seok, Im, Young-Hyuck, Park, Yeon Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926822/ https://www.ncbi.nlm.nih.gov/pubmed/33671539 http://dx.doi.org/10.3390/diagnostics11020370

Ejemplares similares

Clinical Characteristics of Korean Breast Cancer Patients Who Carry Pathogenic Germline Mutations in Both BRCA1 and BRCA2: A Single-Center Experience
por: Hur, Joon Young, et al.
Publicado: (2020)

Urological myriad
Publicado: (2018)

Comprehensive clinical characterization of patients with BRCA1: c.5017_5019del germline variant
por: Bang, Yoon Ju, et al.
Publicado: (2022)

Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: result of an institution database from South Korea
por: Kim, Hee Kyung, et al.
Publicado: (2019)

Myriad Cardiac Manifestation of Hyperhomocysteinemia
por: Babu, Jai, et al.
Publicado: (2015)

The myriad possibility of kidney organoids
por: Tian, Pinyuan, et al.
Publicado: (2019)

The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans
por: Kim, Hakyoung, et al.
Publicado: (2019)

Clinicopathologic Features and Long-Term Outcomes of Elderly Breast Cancer Patients: Experiences at a Single Institution in Korea
por: Kim, Hee Kyung, et al.
Publicado: (2016)

Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics Saga
por: So, Derek, et al.
Publicado: (2013)

Myriads of protein families, and still counting
por: Kunin, Victor, et al.
Publicado: (2003)

The Myriad Properties of Pasteurella multocida Lipopolysaccharide
por: Harper, Marina, et al.
Publicado: (2017)

Guidelines for the Laboratory Diagnosis of Monkeypox in Korea
por: Hong, Ki Ho, et al.
Publicado: (2023)

Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers
por: Lee, Young-Jae, et al.
Publicado: (2017)

Chip Intel Myriad2 tested at CERN
por: Brice, Maximilien
Publicado: (2018)

Meta-Analysis a Myriad of Data – Is It Helpful?
por: Harrop, James
Publicado: (2019)

Myriad Presentations of Intracranial Meningiomas: Pictoral Essay
por: Dhagat, Peeyush Kumar
Publicado: (2022)

Myriad applications of bacteriophages beyond phage therapy
por: García-Cruz, Juan Carlos, et al.
Publicado: (2023)

The germline mutational landscape of BRCA1 and BRCA2 in Brazil
por: Palmero, Edenir Inêz, et al.
Publicado: (2018)

Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea
por: Kim, Se Ik, et al.
Publicado: (2020)

Real World Experience of Second-Line Treatment Strategies after Palbociclib and Letrozole: Overall Survival in Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2023)

Update of Guidelines for Laboratory Diagnosis of COVID-19 in Korea
por: Hong, Ki Ho, et al.
Publicado: (2022)

A comparative study of germline BRCA1 and BRCA2 mutation screening methods in use in 20 European clinical diagnostic laboratories
por: Ellison, Gillian, et al.
Publicado: (2017)

Efficiency of BRCAPRO and Myriad II mutation probability thresholds versus cancer history criteria alone for BRCA1/2 mutation detection
por: van Harssel, J. J. T., et al.
Publicado: (2009)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)

Which Clinicopathologic Parameters Suggest Primary Resistance to Palbociclib in Combination With Letrozole as the First-Line Treatment for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer?
por: Kim, Ji-Yeon, et al.
Publicado: (2021)

Novel Germline Mutations of BRCA1 and BRCA2 in Korean Familial Breast Cancer Patients
por: Kim, Hee Nam, et al.
Publicado: (2019)

Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical Experience
por: Kim, Ji-Yeon, et al.
Publicado: (2022)

BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
por: Purnomosari, Dewajani, et al.
Publicado: (2007)

Laboratory Verification of a BRCA1 and BRCA2 Massively Parallel Sequencing Assay from Wet Bench to Bioinformatics for Germline DNA Analysis
por: Poon, Kok-Siong, et al.
Publicado: (2021)

SNOntology: Myriads of novel snornas or just a mirage?
por: Makarova, Julia A, et al.
Publicado: (2011)

SFPH proteins as therapeutic targets for a myriad of diseases
por: Wang, Dong, et al.
Publicado: (2020)

The myriad ways in which COVID-19 revealed character
por: Seijts, Gerard, et al.
Publicado: (2021)

T Cells in Viral Infections: The Myriad Flavours of Antiviral Immunity
por: Jagadeesh, Achanta, et al.
Publicado: (2019)

MON-LB041 Pheochromocytoma - Illusive Myriad of Symptoms
por: Gunda, Mouna, et al.
Publicado: (2020)

Tunable mode control through myriad-mode fibers
por: Singh, Sakshi, et al.
Publicado: (2021)

Evaluation of Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Experience in a Single Institution over a 10-Year Period
por: Choi, Misun, et al.
Publicado: (2017)

Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea
por: Hong, Ki Ho, et al.
Publicado: (2020)

Real-World Data from a Refractory Triple-Negative Breast Cancer Cohort Selected Using a Clinical Data Warehouse Approach
por: Kim, Hana, et al.
Publicado: (2021)

Evaluation of models to predict BRCA germline mutations
por: Kang, H H, et al.
Publicado: (2006)

BRCA1 Norway: comparison of classification for BRCA1 germline variants detected in families with suspected hereditary breast and ovarian cancer between different laboratories
por: Hovland, Henrikke N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f8m942dusahgv1khkso8vtf91u